<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03747627</url>
  </required_header>
  <id_info>
    <org_study_id>MS001</org_study_id>
    <nct_id>NCT03747627</nct_id>
  </id_info>
  <brief_title>BPF Genetics of ILD Study</brief_title>
  <acronym>BPF GILD</acronym>
  <official_title>British Pigeon Fanciers Genetics of Interstitial Lung Disease Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dundee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newcastle University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>British Lung Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>British Pigeon Fanciers Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Dundee</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to examine the genetic determinants of interstitial lung disease in a&#xD;
      cohort of subjects with regular exposure to pigeons, a known cause of one form of&#xD;
      interstitial lung disease known as hypersensitivity pneumonitis. In addition we will examine&#xD;
      immunological causes for hypersensitivity pneumonitis in this group.&#xD;
&#xD;
      We anticipate our work will provide insights of use to clinicians and patients with&#xD;
      hypersensitivity pneumonitis and other interstitial lung diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to recruit participants with regular racing pigeon exposure at national&#xD;
      (UK) and regional pigeon fancier meetings.&#xD;
&#xD;
      Consenting subjects will complete questionnaires, provide blood samples for genetic analysis&#xD;
      and immunological testing and undertake lung function measurements.&#xD;
&#xD;
      Subjects will be observed, and encouraged to report referral to specialist respiratory&#xD;
      services, and following this information will be sought on diagnosis (including supporting&#xD;
      evidence). Where interstitial lung disease is detected this will be linked to subsequent&#xD;
      unbiased analysis to detect potential predisposing genetic associations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">January 22, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Relationship of specific genetic markers to development of interstitial lung disease</measure>
    <time_frame>5 years</time_frame>
    <description>Participants will be screened for MUC5B genetic profile to allow examination of MUC5B genetic profile relationship with risk of developing interstitial lung disease in this group</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Lung; Disease, Interstitial, With Fibrosis</condition>
  <condition>Alveolitis, Extrinsic Allergic</condition>
  <condition>Bird Fancier's Lung</condition>
  <condition>Idiopathic Interstitial Pneumonias</condition>
  <condition>Lung Diseases, Interstitial</condition>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Genetic profiling</intervention_name>
    <description>All participating subjects will undergo detailed genetic analysis, with the aim of detecting novel genetic drivers for the development of interstitial lung disease in the context of known sensitising agent (pigeon antigen)</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be prepared for DNA analysis&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in the sport of Pigeon racing&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  regular exposure to racing pigeons&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Spears, PhD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>NHS Tayside</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Spears, PhD, FRCP</last_name>
    <phone>+44 1738 473384</phone>
    <email>mark.spears@nhs.scot</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liz Coote</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Pigeon Racing Association Meeting</name>
      <address>
        <city>Blackpool</city>
        <zip>FY1 1HL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Spears, PhD FRCP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scottish Homing Union</name>
      <address>
        <city>Lanark</city>
        <zip>ML11 9AX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NHS Tayside</investigator_affiliation>
    <investigator_full_name>Mark Spears</investigator_full_name>
    <investigator_title>Dr Mark Spears, Consultant in Respiratory Medicine</investigator_title>
  </responsible_party>
  <keyword>Interstitial Lung Disease (ILD)</keyword>
  <keyword>Hypersensitivity Pneumonitis</keyword>
  <keyword>Idiopathic Pulmonary Fibrosis (IPF)</keyword>
  <keyword>Extrinsic Allergic Alveolitis (EAA)</keyword>
  <keyword>Bird Fancier's Lung</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
    <mesh_term>Hamman-Rich Syndrome</mesh_term>
    <mesh_term>Bird Fancier's Lung</mesh_term>
    <mesh_term>Alveolitis, Extrinsic Allergic</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Will be considered, dependent on potential for increased power</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

